A phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma
暂无分享,去创建一个
A. Hauschild | J. Kirkwood | P. Hersey | P. Lorigan | C. Robert | J. Gómez-Navarro | D. McDermott | C. Bulanhagui | J. Liang
暂无分享,去创建一个
A. Hauschild | J. Kirkwood | P. Hersey | P. Lorigan | C. Robert | J. Gómez-Navarro | D. McDermott | C. Bulanhagui | J. Liang